vs
Side-by-side financial comparison of Cardiff Oncology, Inc. (CRDF) and MICROVISION, INC. (MVIS). Click either name above to swap in a different company.
Cardiff Oncology, Inc. is the larger business by last-quarter revenue ($243.0K vs $223.0K, roughly 1.1× MICROVISION, INC.). On growth, Cardiff Oncology, Inc. posted the faster year-over-year revenue change (62.0% vs -86.5%). Over the past eight quarters, Cardiff Oncology, Inc.'s revenue compounded faster (8.9% CAGR vs -51.7%).
MicroVision Inc. is a technology company specializing in advanced LiDAR sensors, miniature display solutions, and perception software. Its core products serve automotive ADAS, augmented reality devices, consumer electronics, and industrial automation markets, delivering high-precision, low-power sensing technologies for next-generation smart applications.
CRDF vs MVIS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $243.0K | $223.0K |
| Net Profit | $-7.2M | — |
| Gross Margin | — | — |
| Operating Margin | -3221.0% | — |
| Net Margin | -2969.5% | — |
| Revenue YoY | 62.0% | -86.5% |
| Net Profit YoY | 38.8% | -21.2% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $243.0K | $223.0K | ||
| Q3 25 | $120.0K | $241.0K | ||
| Q2 25 | $121.0K | $155.0K | ||
| Q1 25 | $109.0K | $589.0K | ||
| Q4 24 | $150.0K | $1.6M | ||
| Q3 24 | $165.0K | $190.0K | ||
| Q2 24 | $163.0K | $1.9M | ||
| Q1 24 | $205.0K | $956.0K |
| Q4 25 | $-7.2M | — | ||
| Q3 25 | $-11.3M | $-14.2M | ||
| Q2 25 | $-13.9M | $-14.2M | ||
| Q1 25 | $-13.4M | $-28.8M | ||
| Q4 24 | $-11.8M | $-31.2M | ||
| Q3 24 | $-11.9M | $-15.5M | ||
| Q2 24 | $-11.8M | $-23.9M | ||
| Q1 24 | $-10.0M | $-26.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | — | -149.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 18.2% | ||
| Q1 24 | — | -33.6% |
| Q4 25 | -3221.0% | — | ||
| Q3 25 | -9978.3% | -5278.4% | ||
| Q2 25 | -12212.4% | -9455.5% | ||
| Q1 25 | -13194.5% | -2383.7% | ||
| Q4 24 | -8381.3% | -1119.5% | ||
| Q3 24 | -7637.0% | -8266.3% | ||
| Q2 24 | -7696.3% | -1296.4% | ||
| Q1 24 | -5333.2% | -2793.9% |
| Q4 25 | -2969.5% | — | ||
| Q3 25 | -9381.7% | -5899.2% | ||
| Q2 25 | -11523.1% | -9180.0% | ||
| Q1 25 | -12324.8% | -4886.1% | ||
| Q4 24 | -7858.0% | -1888.2% | ||
| Q3 24 | -7184.8% | -8166.8% | ||
| Q2 24 | -7225.8% | -1259.5% | ||
| Q1 24 | -4883.4% | -2752.4% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.17 | $-0.05 | ||
| Q2 25 | $-0.21 | $-0.06 | ||
| Q1 25 | $-0.20 | $-0.12 | ||
| Q4 24 | $-0.22 | $-0.15 | ||
| Q3 24 | $-0.25 | $-0.07 | ||
| Q2 24 | $-0.26 | $-0.11 | ||
| Q1 24 | $-0.22 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.3M | $74.9M |
| Total DebtLower is stronger | — | $19.2M |
| Stockholders' EquityBook value | $45.4M | $55.5M |
| Total Assets | $61.9M | $103.1M |
| Debt / EquityLower = less leverage | — | 0.35× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.3M | $74.9M | ||
| Q3 25 | $60.6M | $99.5M | ||
| Q2 25 | $71.0M | $91.4M | ||
| Q1 25 | $79.9M | $69.0M | ||
| Q4 24 | $91.7M | $74.7M | ||
| Q3 24 | $57.7M | $43.2M | ||
| Q2 24 | $60.3M | $56.6M | ||
| Q1 24 | $67.2M | $73.1M |
| Q4 25 | — | $19.2M | ||
| Q3 25 | — | $29.0M | ||
| Q2 25 | — | $32.3M | ||
| Q1 25 | — | $30.1M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $45.4M | $55.5M | ||
| Q3 25 | $48.8M | $90.7M | ||
| Q2 25 | $58.6M | $77.1M | ||
| Q1 25 | $70.9M | $53.2M | ||
| Q4 24 | $82.9M | $48.8M | ||
| Q3 24 | $49.4M | $65.9M | ||
| Q2 24 | $52.4M | $78.7M | ||
| Q1 24 | $60.9M | $93.8M |
| Q4 25 | $61.9M | $103.1M | ||
| Q3 25 | $63.8M | $150.8M | ||
| Q2 25 | $75.7M | $140.6M | ||
| Q1 25 | $84.8M | $116.7M | ||
| Q4 24 | $97.2M | $121.2M | ||
| Q3 24 | $62.9M | $88.3M | ||
| Q2 24 | $66.1M | $103.4M | ||
| Q1 24 | $74.0M | $124.2M |
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.42× | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | — | 0.68× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-58.7M |
| Free Cash FlowOCF − Capex | — | $-59.4M |
| FCF MarginFCF / Revenue | — | -26636.3% |
| Capex IntensityCapex / Revenue | — | 304.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-103.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $-58.7M | ||
| Q3 25 | $-10.8M | $-16.5M | ||
| Q2 25 | $-8.3M | $-12.7M | ||
| Q1 25 | $-12.8M | $-14.1M | ||
| Q4 24 | $-10.3M | $-15.1M | ||
| Q3 24 | $-10.5M | $-14.1M | ||
| Q2 24 | $-9.2M | $-18.6M | ||
| Q1 24 | $-7.7M | $-20.8M |
| Q4 25 | — | $-59.4M | ||
| Q3 25 | $-10.9M | $-16.6M | ||
| Q2 25 | — | $-12.9M | ||
| Q1 25 | — | $-14.2M | ||
| Q4 24 | — | $-15.2M | ||
| Q3 24 | — | $-14.1M | ||
| Q2 24 | — | $-18.8M | ||
| Q1 24 | $-7.8M | $-20.9M |
| Q4 25 | — | -26636.3% | ||
| Q3 25 | -9043.3% | -6894.6% | ||
| Q2 25 | — | -8346.5% | ||
| Q1 25 | — | -2410.4% | ||
| Q4 24 | — | -918.7% | ||
| Q3 24 | — | -7421.1% | ||
| Q2 24 | — | -989.5% | ||
| Q1 24 | -3814.6% | -2183.4% |
| Q4 25 | — | 304.5% | ||
| Q3 25 | 15.0% | 53.1% | ||
| Q2 25 | — | 134.2% | ||
| Q1 25 | — | 16.8% | ||
| Q4 24 | 0.0% | 6.2% | ||
| Q3 24 | 0.0% | 4.7% | ||
| Q2 24 | 0.0% | 8.7% | ||
| Q1 24 | 39.0% | 11.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
